Kenneth R. Carson
Experienced in Lymphofollicular Hyperplasia

Dr. Kenneth R. Carson

Hematology | Oncology
Northwestern Medical Group
675 N St Clair St Ste 21-100, Galter Pavilion, 
Chicago, IL 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
26 Years of Experience
Experienced in Lymphofollicular Hyperplasia
Northwestern Medical Group
675 N St Clair St Ste 21-100, Galter Pavilion, 
Chicago, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Kenneth Carson is a Hematologist and an Oncologist in Chicago, Illinois. Dr. Carson has been practicing medicine for over 26 years and is rated as an Experienced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant.

His clinical research consists of co-authoring 100 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles and participated in 1 clinical trial in the study of Lymphofollicular Hyperplasia.

Graduate Institution
University Of Southern California Keck School Of Medicine, 2000.0
Residency
Duke University Hospital
Specialties
Hematology
Oncology
Licenses
Internal Medicine in MO
Board Certifications
American Board Of Internal Medicine - Hematology (Certified)
Hospital Affiliations
Northwestern Memorial Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Network Health
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

675 N St Clair St Ste 21-100, Galter Pavilion, Chicago, IL 60611
Call: 866-587-4322

Additional Areas of Focus

Dr. Carson has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Tempus Small Cell Lung Cancer Observational Study (Sculptor): A Tissue and Longitudinal Circulating Tumor DNA (ctDNA) Biomarker Profiling Study of Patients With Small Cell Lung Cancer (SCLC) Using Comprehensive Next-Generation Sequencing (NGS) Assays
Tempus Small Cell Lung Cancer Observational Study (Sculptor): A Tissue and Longitudinal Circulating Tumor DNA (ctDNA) Biomarker Profiling Study of Patients With Small Cell Lung Cancer (SCLC) Using Comprehensive Next-Generation Sequencing (NGS) Assays
Enrollment Status: Recruiting
Publish Date: May 06, 2025
Intervention Type: Other
Effect of Vitamin D Replacement on Tumor Response and Survival Parameters for Vitamin D Insufficient Patients With Cancer
Effect of Vitamin D Replacement on Tumor Response and Survival Parameters for Vitamin D Insufficient Patients With Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 13, 2025
Intervention Type: Dietary supplement, Other
Study Drug: Cholecalciferol
Study Phase: Not Applicable
Tempus Priority Study: An Observational Study of Patients Who Have Received Comprehensive Genomic Profiling
Tempus Priority Study: An Observational Study of Patients Who Have Received Comprehensive Genomic Profiling
Enrollment Status: Active_not_recruiting
Publish Date: May 06, 2025
Intervention Type: Other
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study
Enrollment Status: Withdrawn
Publish Date: June 22, 2023
A Phase I Trial of Brentuximab Vedotin in Combination With Lenalidomide in Relapsed or Refractory Diffuse Large B-cell Lymphoma
A Phase I Trial of Brentuximab Vedotin in Combination With Lenalidomide in Relapsed or Refractory Diffuse Large B-cell Lymphoma
Enrollment Status: Completed
Publish Date: February 17, 2022
Intervention Type: Drug
Study Drugs: Brentuximab vedotin, Lenalidomide
Study Phase: Phase 1
A Phase I/II Study of X-82, an Oral Anti-VEGFR Tyrosine Kinase Inhibitor, With Everolimus for Patients With Pancreatic Neuroendocrine Tumors
A Phase I/II Study of X-82, an Oral Anti-VEGFR Tyrosine Kinase Inhibitor, With Everolimus for Patients With Pancreatic Neuroendocrine Tumors
Enrollment Status: Terminated
Publish Date: July 08, 2021
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Blinded, Prospective Non-Interventional Observational Study for the Evaluation of a GVHD Negative Outcome Score (GNOS) in Matched Unrelated or Haploidentical Hematopoietic Stem Cell Transplant
A Blinded, Prospective Non-Interventional Observational Study for the Evaluation of a GVHD Negative Outcome Score (GNOS) in Matched Unrelated or Haploidentical Hematopoietic Stem Cell Transplant
Enrollment Status: Completed
Publish Date: February 04, 2021
A Multicenter Phase I Dose-finding and Preliminary Efficacy Study of the Histone Deacetylase Inhibitor Romidepsin (Istodax) in Combination With Gemcitabine (Gemzar), Oxaliplatin (Eloxatin), and Dexamethasone for the Treatment of Adults With Relapsed/Refractory Aggressive Lymphomas
A Multicenter Phase I Dose-finding and Preliminary Efficacy Study of the Histone Deacetylase Inhibitor Romidepsin (Istodax) in Combination With Gemcitabine (Gemzar), Oxaliplatin (Eloxatin), and Dexamethasone for the Treatment of Adults With Relapsed/Refractory Aggressive Lymphomas
Enrollment Status: Completed
Publish Date: November 17, 2020
Intervention Type: Drug
Study Phase: Phase 1
Prospective Collection of Data in Pts With Peripheral T-Cell Lymphoma: PTCL,NOS;AITL; Extranodal NK/T-cell;Enteropathy-type; Hepatosplenic γ-δ; Subcutaneous Panniculitis-like; ALCL,Primary Systemic Type. By the Intl. T-Cell Lymphoma Project
Prospective Collection of Data in Pts With Peripheral T-Cell Lymphoma: PTCL,NOS;AITL; Extranodal NK/T-cell;Enteropathy-type; Hepatosplenic γ-δ; Subcutaneous Panniculitis-like; ALCL,Primary Systemic Type. By the Intl. T-Cell Lymphoma Project
Enrollment Status: Completed
Publish Date: July 08, 2019
View 8 Less Clinical Trials

100 Total Publications

Cancer Drugs and United States Tariffs: Attention Must Be Paid.
Cancer Drugs and United States Tariffs: Attention Must Be Paid.
Journal: Cancer journal (Sudbury, Mass.)
Published: May 29, 2025
View All 100 Publications
Similar Doctors
Ronald J. Shade
Distinguished in Lymphofollicular Hyperplasia
Dr. Ronald J. Shade
Hematology | Oncology
Distinguished in Lymphofollicular Hyperplasia
Dr. Ronald J. Shade
Hematology | Oncology

Northwest Oncology And Hematology SC

3701 Algonquin Road, Ste 900, Designated Parking Is Located On The Far West Side Of The Building. Take Elevators To 9th Floor., 
Rolling Meadows, IL 
 (23.9 miles away)
847-437-3312
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ronald Shade is a Hematologist and an Oncologist in Rolling Meadows, Illinois. Dr. Shade is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Colorectal Cancer, Lung Cancer, and Bone Marrow Aspiration.

Jayanthi R. Ramadurai
Distinguished in Lymphofollicular Hyperplasia
Dr. Jayanthi R. Ramadurai
Hematology | Oncology
Distinguished in Lymphofollicular Hyperplasia
Dr. Jayanthi R. Ramadurai
Hematology | Oncology

Affiliated Oncologists, LLC

10604 Southwest Hwy, 
Chicago Ridge, IL 
 (16.5 miles away)
708-634-4644
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jayanthi Ramadurai is a Hematologist and an Oncologist in Chicago Ridge, Illinois. Dr. Ramadurai is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. Her top areas of expertise are Severe Congenital Neutropenia, Paget Disease of the Breast, Breast Cancer, and Agranulocytosis.

Distinguished in Lymphofollicular Hyperplasia
Dr. Gowri Ramadas
Hematology | Oncology
Distinguished in Lymphofollicular Hyperplasia
Dr. Gowri Ramadas
Hematology | Oncology

Northwest Cancer Centers PC

342 E 109th Ave, Northwest Cancer Ctr, 
Crown Point, IN 
 (35.9 miles away)
219-310-2550
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Gowri Ramadas is a Hematologist and an Oncologist in Crown Point, Indiana. Dr. Ramadas has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Pleuropulmonary Blastoma, and Lymphofollicular Hyperplasia.

VIEW MORE LYMPHOFOLLICULAR HYPERPLASIA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Carson's expertise for a condition
ConditionClose
    • Distinguished
    • Multiple Myeloma
      Dr. Carson is
      Distinguished
      . Learn about Multiple Myeloma.
      See more Multiple Myeloma experts
    • Non-Hodgkin Lymphoma
      Dr. Carson is
      Distinguished
      . Learn about Non-Hodgkin Lymphoma.
      See more Non-Hodgkin Lymphoma experts
    • Peripheral T-Cell Lymphoma
      Dr. Carson is
      Distinguished
      . Learn about Peripheral T-Cell Lymphoma.
      See more Peripheral T-Cell Lymphoma experts
    • T-Cell Lymphoma
      Dr. Carson is
      Distinguished
      . Learn about T-Cell Lymphoma.
      See more T-Cell Lymphoma experts
    • Venous Thromboembolism (VTE)
      Dr. Carson is
      Distinguished
      . Learn about Venous Thromboembolism (VTE).
      See more Venous Thromboembolism (VTE) experts
    • Advanced
    • Anaplastic Large Cell Lymphoma
      Dr. Carson is
      Advanced
      . Learn about Anaplastic Large Cell Lymphoma.
      See more Anaplastic Large Cell Lymphoma experts
    • Angioimmunoblastic T-cell Lymphoma
      Dr. Carson is
      Advanced
      . Learn about Angioimmunoblastic T-cell Lymphoma.
      See more Angioimmunoblastic T-cell Lymphoma experts
    • B-Cell Lymphoma
      Dr. Carson is
      Advanced
      . Learn about B-Cell Lymphoma.
      See more B-Cell Lymphoma experts
    • Burkitt Lymphoma
      Dr. Carson is
      Advanced
      . Learn about Burkitt Lymphoma.
      See more Burkitt Lymphoma experts
    • Cutaneous T-Cell Lymphoma (CTCL)
      Dr. Carson is
      Advanced
      . Learn about Cutaneous T-Cell Lymphoma (CTCL).
      See more Cutaneous T-Cell Lymphoma (CTCL) experts
    • Diffuse Large B-Cell Lymphoma (DLBCL)
      Dr. Carson is
      Advanced
      . Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
      See more Diffuse Large B-Cell Lymphoma (DLBCL) experts
    View All 11 Advanced Conditions
    • Experienced
    • Agranulocytosis
      Dr. Carson is
      Experienced
      . Learn about Agranulocytosis.
      See more Agranulocytosis experts
    • Anal Cancer
      Dr. Carson is
      Experienced
      . Learn about Anal Cancer.
      See more Anal Cancer experts
    • Anemia
      Dr. Carson is
      Experienced
      . Learn about Anemia.
      See more Anemia experts
    • Bone Marrow Aspiration
      Dr. Carson is
      Experienced
      . Learn about Bone Marrow Aspiration.
      See more Bone Marrow Aspiration experts
    • Bone Marrow Transplant
      Dr. Carson is
      Experienced
      . Learn about Bone Marrow Transplant.
      See more Bone Marrow Transplant experts
    • Breast Cancer in Men
      Dr. Carson is
      Experienced
      . Learn about Breast Cancer in Men.
      See more Breast Cancer in Men experts
    View All 26 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.